|
CA2264012C
(en)
*
|
1996-08-13 |
2011-04-26 |
Chiron Corporation |
Compositions and methods for polynucleotide delivery
|
|
US6635623B1
(en)
|
1997-06-13 |
2003-10-21 |
Baylor College Of Medicine |
Lipoproteins as nucleic acid vectors
|
|
AU8692598A
(en)
|
1997-08-04 |
1999-02-22 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
|
US6197332B1
(en)
|
1997-08-13 |
2001-03-06 |
Chiron Corporation |
Lipid-conjugated polyamide compounds and related compositions and methods thereof
|
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
|
US6344541B1
(en)
*
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
|
DK1149114T3
(da)
|
1999-02-03 |
2014-06-23 |
Amgen Inc |
Polypeptider, der er involveret ved et immunrespons
|
|
US7708993B2
(en)
*
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
|
AU3770800A
(en)
|
1999-03-26 |
2000-10-16 |
Amgen, Inc. |
Beta secretase genes and polypeptides
|
|
US6281005B1
(en)
|
1999-05-14 |
2001-08-28 |
Copernicus Therapeutics, Inc. |
Automated nucleic acid compaction device
|
|
EP1209971A4
(en)
*
|
1999-08-20 |
2004-04-14 |
Mirus Corp |
POLYION COMPLEX LOAD INVERSION
|
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
|
US7408047B1
(en)
*
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
|
US6900043B1
(en)
*
|
1999-09-21 |
2005-05-31 |
Amgen Inc. |
Phosphatases which activate map kinase pathways
|
|
US20050239061A1
(en)
*
|
2000-03-01 |
2005-10-27 |
Marshall William S |
Identification and use of effectors and allosteric molecules for the alteration of gene expression
|
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
|
WO2002000710A2
(en)
*
|
2000-06-28 |
2002-01-03 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
|
JP2004519205A
(ja)
|
2000-06-28 |
2004-07-02 |
アムジェン インコーポレイテッド |
胸腺間質リンホポイエチンレセプター分子およびその使用
|
|
WO2002044364A2
(en)
|
2000-11-28 |
2002-06-06 |
Amgen Inc. |
Polypeptides involved in immune response
|
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
|
AU2003217693A1
(en)
*
|
2002-02-22 |
2003-09-09 |
Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
|
US7662924B2
(en)
*
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
|
WO2003078576A2
(en)
*
|
2002-03-12 |
2003-09-25 |
Nitto Denko Corporation |
Vector for transfection of eukaryotic cells
|
|
GB0212826D0
(en)
*
|
2002-05-31 |
2002-07-10 |
Dna Res Innovations Ltd |
Materials and methods relating to polyions and substance delivery
|
|
PL378879A1
(pl)
*
|
2002-12-30 |
2006-05-29 |
Amgen Inc. |
Terapia skojarzona z czynnikami kostymulującymi
|
|
EP1773998A2
(en)
*
|
2004-04-20 |
2007-04-18 |
Nastech Pharmaceutical Company Inc. |
Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
|
|
US20060040882A1
(en)
*
|
2004-05-04 |
2006-02-23 |
Lishan Chen |
Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
|
US20060035815A1
(en)
*
|
2004-05-04 |
2006-02-16 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
|
|
WO2006009575A1
(en)
|
2004-06-22 |
2006-01-26 |
The Board Of Trustees Of The University Of Illinois |
METHODS OF INHIBITING TUMOR CELL PROLIFERATION WITH FOXM1 siRNA
|
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
|
JP2009507852A
(ja)
*
|
2005-09-08 |
2009-02-26 |
エムディーアールエヌエー，インコーポレイテッド |
リボ核酸の細胞への送達用医薬組成物
|
|
US20100129460A1
(en)
*
|
2005-10-14 |
2010-05-27 |
Nastech Pharmaceutical Company Inc. |
Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics
|
|
US20070281900A1
(en)
*
|
2006-05-05 |
2007-12-06 |
Nastech Pharmaceutical Company Inc. |
COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY
|
|
US20070269892A1
(en)
*
|
2006-05-18 |
2007-11-22 |
Nastech Pharmaceutical Company Inc. |
FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA
|
|
US20070275923A1
(en)
*
|
2006-05-25 |
2007-11-29 |
Nastech Pharmaceutical Company Inc. |
CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
|
|
US8282918B2
(en)
*
|
2007-07-30 |
2012-10-09 |
University Of Iowa Research Foundation |
Polynucleotides encoding RPA4/RPA32 hybrid polypeptides
|
|
WO2009051451A2
(en)
*
|
2007-10-17 |
2009-04-23 |
Korea Advanced Institute Of Science And Technology |
Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
|
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
|
EA201990619A1
(ru)
|
2008-10-10 |
2019-07-31 |
Амген Инк. |
Fgf21 мутанты и их применение
|
|
US20120052069A1
(en)
|
2009-05-05 |
2012-03-01 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
|
SG10201402038WA
(en)
|
2009-05-05 |
2014-07-30 |
Amgen Inc |
FGF21 Mutants And Uses Thereof
|
|
AU2010262927A1
(en)
*
|
2009-06-17 |
2012-01-19 |
Amgen Inc. |
Chimeric FGF19 polypeptides and uses thereof
|
|
TWI373338B
(en)
*
|
2009-08-27 |
2012-10-01 |
Nat Univ Chung Cheng |
Pharmaceutical composition containing transcription factor decoys and their preparation method and applications
|
|
EP2497830A1
(en)
|
2009-11-05 |
2012-09-12 |
Proyecto de Biomedicina Cima, S.L. |
Regulated expression systems
|
|
JP2013512672A
(ja)
*
|
2009-12-02 |
2013-04-18 |
アムジエン・インコーポレーテツド |
ヒトＦＧＦＲ１ｃ、ヒトβ−クロト−、ならびにヒトＦＧＦＲ１ｃおよびヒトβ−クロト−の両方に結合する結合タンパク質
|
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
|
JP2013523184A
(ja)
|
2010-04-15 |
2013-06-17 |
アムジエン・インコーポレーテツド |
ヒトＦＧＦ受容体およびβ−ＫＬＯＴＨＯ結合性タンパク質
|
|
US9273316B2
(en)
|
2010-05-21 |
2016-03-01 |
Peptimed, Inc. |
Reagents and methods for treating cancer
|
|
WO2012095548A2
(es)
|
2011-01-13 |
2012-07-19 |
Centro De Investigación Biomédica En Red De Enfermedades Neurodegenerativas (Ciberned) |
Compuestos para el tratamiento de enfermedades neurodegenerativas
|
|
US9644038B2
(en)
|
2011-12-21 |
2017-05-09 |
The Regents Of The University Of California |
Apolipoprotein nanodiscs with telodendrimer
|
|
US10005936B2
(en)
*
|
2012-11-23 |
2018-06-26 |
Nanyang Technological University |
Photoactive bioadhesive compositions
|
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
|
PH12022550138A1
(en)
|
2013-03-13 |
2023-03-06 |
Amgen Inc |
Proteins specific for baff and b7rp1 and uses thereof
|
|
CA2931547A1
(en)
|
2013-12-09 |
2015-06-18 |
Durect Corporation |
Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
|
|
US12226529B2
(en)
|
2015-08-25 |
2025-02-18 |
Lawrence Livermore National Security, Llc |
Stable nanolipoprotein particles and related compositions methods and systems
|
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
|
US12083223B2
(en)
*
|
2017-05-02 |
2024-09-10 |
Lawrence Livermore National Security, Llc |
Nanolipoprotein particles and related compositions methods and systems for loading RNA
|
|
WO2018204421A2
(en)
|
2017-05-02 |
2018-11-08 |
Lawrence Livermore National Security, Llc |
Momp telonanoparticles, and related compositions, methods and systems
|
|
AR120309A1
(es)
|
2019-10-28 |
2022-02-09 |
Medimmune Ltd |
Formulaciones de polvo seco de anticuerpos que se unen a la linfopoyetina del estroma tímico (tslp) y métodos de uso de las mismas
|